Rivus Pharmaceuticals Inc., a clinical-stage biopharmaceutical company dedicated to improving cardio-metabolic health, announced the completion of a $132 million Series B financing led by...
EOFlow Co., Ltd., a provider of wearable drug delivery solutions, has announced that its wholly owned US subsidiary, EOFlow Inc. has signed an agreement...
